NCT02988362View on ClinicalTrials.gov

Bioequivalence Study (Candesartan 16 mg and Amlodipine 10 mg)

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

December 14, 2016

Primary Completion Date

February 4, 2017

Study Completion Date

February 4, 2017

Conditions
Hypertension
Interventions
DRUG

HL068 16/10mg

Candesartan 16mg and Amlodipine 10mg

DRUG

Candesartan 16mg and Amlodipine 10mg

Sponsors
All Listed Sponsors
lead

HanAll BioPharma Co., Ltd.

INDUSTRY

NCT02988362 - Bioequivalence Study (Candesartan 16 mg and Amlodipine 10 mg) | Biotech Hunter | Biotech Hunter